Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMT and Psychotherapy for Alcohol Use Disorder
NCT06070649Phase 1Recruiting
- Sponsor
- Yale University
- Start
- Aug 2025
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of DMT in alcohol use disorder (AUD) (3 arms), sponsored by Yale University. Primary endpoints: Safety and tolerability of DMT and Effects of DMT on alcohol consumption. Started Aug 2025; status: recruiting.
02
Drugs
DMT
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT06070649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06070649.